Novel method for isolating endotoxins

Abstract

The invention concerns a novel method for extracting endotoxins from bacteria, and the use of said method for preparing compositions comprising endotoxins or derivatives thereof designed for human or animal use (scientific, medical usage).

1 - 15 . (canceled) 
     
     
         16 . A method for isolating one or more endotoxins, comprising:
 suspending a group of bacterial cells or a culture supernatant, wherein the bacterial cells or the culture supernatant contain the endotoxins, in a mixture of solvents containing:   10 to 90% of a solvent chosen from: linear or branched aliphatic acids containing from 3 to 6 carbon atoms, and   90 to 10% of a basic aqueous solution of an aliphatic amine containing from 0 to 12 carbon atoms;   stirring the suspended bacterial cells or a culture supernatant to produce a solution of bacterial endotoxins in the mixture of solvents containing suspended particles of cell debris: and   separating the particles from the solution by (1) filtration, (2) centrifugation and recovery of the supernatant or (3) centrifugation followed by the filtration of the supernatant, wherein the endotoxins are not obtained in combination with silica, and wherein the bacterial cells are  Escherichia coli, Bordetella parapertussis, Salmonella, Shigella, Pseudomonas, Neisseria  or  Haemophilus.      
     
     
         17 . The method of  claim 16 , wherein the solvents are eliminated from the supernatant or from the filtrate containing endotoxins, by means of a method chosen from: dialysis, filtration/washing, or precipitation. 
     
     
         18 . The method of  claim 17 , further comprising extracting the endotoxins with a mixture of chloroform and methanol. 
     
     
         19 . The method of  claim 16 , wherein the mixture of solvents contains:
 30 to 70% of a solvent chosen from linear or branched aliphatic acids containing from 3 to 6 carbon atoms,   70 to 30% of a basic aqueous solution of an aliphatic amine containing from 0 to 12 carbon atoms.   
     
     
         20 . The method of  claim 16 , wherein the mixture of solvents is isobutyric acid and triethylamine in a 10% aqueous solution, in a 5/3 ratio by volume. 
     
     
         21 . The method of  claim 16 , wherein the mixture of solvents is a mixture of isobutyric acid and of aqueous ammonia in a molar aqueous solution, in a 5/3 ratio by volume. 
     
     
         22 . The method of  claim 16 , wherein the suspending lasts from 5 to 15 minutes. 
     
     
         23 . The method of  claim 16 , wherein the aliphatic amine is ammonia. 
     
     
         24 . The method of  claim 16 , wherein the mixture of solvents consists of:
 10 to 90% of the solvent chosen from: linear or branched aliphatic acids containing from 3 to 6 carbon atoms, and   90 to 10% of the basic aqueous solution of an aliphatic amine containing from 0 to 12 carbon atoms.   
     
     
         25 . A method for isolating one or more endotoxins, comprising:
 suspending 1 gram or more of a group of bacterial cells or a culture supernatant containing 1 gram or more of bacterial cells, wherein the bacterial cells or the culture supernatant contain the endotoxins, in a mixture of solvents containing:   10 to 90% of a solvent chosen from: linear or branched aliphatic acids containing from 3 to 6 carbon atoms, and   90 to 10% of a basic aqueous solution of an aliphatic amine containing from 0 to 12 carbon atoms;   stirring the suspended bacterial cells or a culture supernatant to produce a solution of bacterial endotoxins in the mixture of solvents containing suspended particles of cell debris;   separating the particles from the solution by (1) filtration, (2) centrifugation followed by recovery of the resulting supernatant or (3) centrifugation followed by filtration of the resulting supernatant; and   eliminating solvents from the filtrate or supernatant containing endotoxins, and wherein the bacterial cells are  Escherichia coli, Bordetella parapertussis, Salmonella, Shigella, Pseudomonas, Neisseria  or  Haemophilus.      
     
     
         26 . The method of  claim 25 , wherein the solvents are eliminated from the supernatant or from the filtrate by dialysis, filtration/washing, or precipitation. 
     
     
         27 . The method of  claim 25 , further comprising extracting the endotoxins with a mixture of chloroform and methanol. 
     
     
         28 . The method of  claim 25 , wherein the mixture of solvents contains:
 30 to 70% of a solvent chosen from linear or branched aliphatic acids containing from 3 to 6 carbon atoms,   70 to 30% of a basic aqueous solution of an aliphatic amine containing from 0 to 12 carbon atoms.   
     
     
         29 . The method of  claim 25 , wherein the mixture of solvents is isobutyric acid and triethylamine in a 10% aqueous solution, in a 5/3 ratio by volume. 
     
     
         30 . The method of  claim 25 , wherein the mixture of solvents is a mixture of isobutyric acid and of aqueous ammonia in a molar aqueous solution, in a 5/3 ratio by volume. 
     
     
         31 . The method of  claim 25 , wherein the suspending lasts from 5 to 15 minutes. 
     
     
         32 . The method of  claim 25 , wherein the filtration is carried out on a support having a porosity ranging from 0.1 to 2:m. 
     
     
         33 . The method of  claim 25 , wherein the centrifugation is carried out under the following conditions: 1500 to 3000 g, for 10 to 20 minutes at ambient temperature. 
     
     
         34 . The method of  claim 25 , wherein the aliphatic amine is ammonia. 
     
     
         35 . The method of  claim 25 , wherein the mixture of solvents consists of:
 10 to 90% of the solvent chosen from: linear or branched aliphatic acids containing from 3 to 6 carbon atoms, and   90 to 10% of the basic aqueous solution of an aliphatic amine containing from 0 to 12 carbon atoms.   
     
     
         36 . A method for isolating one or more endotoxins, comprising:
 suspending a group of bacterial cells or a culture supernatant, wherein the bacterial cells or the culture supernatant contain the endotoxins, in a mixture of solvents containing:   10 to 90% of a solvent chosen from: linear or branched aliphatic acids containing from 3 to 6 carbon atoms, and   90 to 10% of a basic aqueous solution of an aliphatic amine containing from 0 to 12 carbon atoms;   stirring the suspended bacterial cells or a culture supernatant to produce a solution of bacterial endotoxins in the mixture of solvents containing suspended particles of cell debris;   separating the particles from the solution by (1) filtration, (2) centrifugation followed by recovery of the resulting supernatant or (3) centrifugation followed by filtration of the resulting supernatant; and   eliminating solvents from the filtrate or supernatant containing endotoxins,   wherein the method is conducted on an industrial scale, and wherein the bacterial cells are  Escherichia coli, Bordetella parapertussis, Salmonella, Shigella, Pseudomonas, Neisseria  or  Haemophilus.      
     
     
         37 . The method of  claim 36 , wherein the solvents are eliminated from the supernatant or from the filtrate dialysis, filtration/washing, or precipitation. 
     
     
         38 . The method of  claim 36 , further comprising extracting the endotoxins with a mixture of chloroform and methanol. 
     
     
         39 . The method of  claim 36 , wherein the mixture of solvents contains:
 30 to 70% of a solvent chosen from linear or branched aliphatic acids containing from 3 to 6 carbon atoms,   70 to 30% of a basic aqueous solution of an aliphatic amine containing from 0 to 12 carbon atoms.   
     
     
         40 . The method of  claim 36 , wherein the mixture of solvents is isobutyric acid and triethylamine in a 10% aqueous solution, in a 5/3 ratio by volume. 
     
     
         41 . The method of  claim 36 , wherein the mixture of solvents is a mixture of isobutyric acid and of aqueous ammonia in a molar aqueous solution, in a 5/3 ratio by volume. 
     
     
         42 . The method of  claim 36 , wherein the suspending lasts from 5 to 15 minutes. 
     
     
         43 . The method of  claim 36 , wherein the filtration is carried out on a support having a porosity ranging from 0.1 to 2:m. 
     
     
         44 . The method of  claim 36 , wherein the centrifugation is carried out under the following conditions: 1500 to 3000 g, for 10 to 20 minutes at ambient temperature. 
     
     
         45 . The method of  claim 36 , wherein the aliphatic amine is ammonia. 
     
     
         46 . The method of  claim 36 , wherein the mixture of solvents consists of:
 10 to 90% of the solvent chosen from: linear or branched aliphatic acids containing from 3 to 6 carbon atoms, and   90 to 10% of the basic aqueous solution of an aliphatic amine containing from 0 to 12 carbon atoms.   
     
     
         47 . A method for isolating one or more endotoxins, comprising:
 suspending a group of bacterial cells or a culture supernatant, wherein the bacterial cells or the culture supernatant contain the endotoxins, in a mixture of solvents containing:   10 to 90% of a solvent chosen from: linear or branched aliphatic acids containing from 3 to 6 carbon atoms, and   90 to 10% of a basic aqueous solution of an aliphatic amine containing from 0 to 12 carbon atoms;   stirring the suspended bacterial cells or a culture supernatant to produce a solution of bacterial endotoxins in the mixture of solvents containing suspended particles of cell debris;   separating the particles from the solution by centrifugation and recovery of the resulting supernatant; and   eliminating solvents from the supernatant containing endotoxins, and wherein  Escherichia coli, Bordetella parapertussis, Salmonella, Shigella, Pseudomonas, Neisseria  or  Haemophilus.      
     
     
         48 . The method of  claim 47 , wherein the solvents are eliminated from the supernatant by dialysis, filtration/washing, or precipitation. 
     
     
         49 . The method of  claim 47 , further comprising extracting the endotoxins with a mixture of chloroform and methanol. 
     
     
         50 . The method of  claim 47 , wherein the mixture of solvents contains:
 30 to 70% of a solvent chosen from linear or branched aliphatic acids containing from 3 to 6 carbon atoms,   70 to 30% of a basic aqueous solution of an aliphatic amine containing from 0 to 12 carbon atoms.   
     
     
         51 . The method of  claim 47 , wherein the mixture of solvents is isobutyric acid and triethylamine in a 10% aqueous solution, in a 5/3 ratio by volume. 
     
     
         52 . The method of  claim 47 , wherein the mixture of solvents is a mixture of isobutyric acid and of aqueous ammonia in a molar aqueous solution, in a 5/3 ratio by volume. 
     
     
         53 . The method of  claim 47 , wherein the suspending lasts from 5 to 15 minutes. 
     
     
         54 . The method of  claim 47 , wherein the centrifugation is carried out under the following conditions: 1500 to 3000 g, for 10 to 20 minutes at ambient temperature. 
     
     
         55 . The method of  claim 47 , wherein the aliphatic amine is ammonia. 
     
     
         56 . The method of  claim 47 , wherein the mixture of solvents consists of:
 10 to 90% of the solvent chosen from: linear or branched aliphatic acids containing from 3 to 6 carbon atoms, and   90 to 10% of the basic aqueous solution of an aliphatic amine containing from 0 to 12 carbon atoms.   
     
     
         57 . A method for preparing a composition comprising one or more
 endotoxins or endotoxin derivatives, intended for human or animal administration, wherein it comprises a step consisting in preparing the endotoxins as claimed in  claim 16 .   
     
     
         58 . The method as claimed in  claim 57 , characterized in that the composition is a therapeutic composition. 
     
     
         59 . The method as claimed in  claim 58  characterized in that the composition is a vaccine composition.